Congratulations to Juan Fernandez-Miranda, MD, on receiving the Fred Gentili Clinical Excellence Award at the 2022 North American Skull Base Society Meeting. The abstract is a collaboration, Ahmed Mohyeldin, MD, and Dr. Fernandez-Miranda. Dr. Mohyeldin conducted the study under Dr. Fernandez-Miranda's direction while completing a skull base fellowship at Stanford.

In the study, the researchers evaluated 107 pituitary adenomas operated on by a single surgeon. In each case, the researchers directly inspected the medial wall of the cavernous sinus, which was surgically removed when invasion was suspected. The authors report that removing the medial wall of the cavernous sinus in acromegaly offers the highest potential for biochemical remission. Though the results were significantly better than previously reported, tue authors noted that longer follow-up is required for definitive conclusions. The research findings may explain the failed biochemical remission rates seen in acromegaly and illustrate the relevance of advanced surgical techniques for successful outcomes in pituitary surgery.

The abstract is titled: Somatotroph Adenomas have a Predilection to Invade the Cavernous Sinus and Resection of the Medial Wall of the Cavernous Sinus Offers the Highest Potential for Biochemical Remission in Acromegaly. 

The abstract authors are: Ahmed Mohyeldin, MD, PhD; Yuanzhi Xu; Maximiliano Alberto Nunez; Ashoke Khanwalker; Zara Patel; Jayakar Nayak; Peter Hwang; Laurence Katznelson; Juan Fernandez-Miranda, MD.